Larvol Delta - Emerald-Health-Pharmaceuticals-Receives-Safety-Review-Committee-Approval-to-Proceed-to-Final-Cohorts-of-EHP101-Phase-2a-Systemic-Sclerosis-Trial

EHP-101 - Emerald Health Pharmaceuticals, Aphios, Emerald Health Research

https://www.globenewswire.com/news-release/2023/01/11/2586901/0/en/Emerald-Health-Pharmaceuticals-Receives-Safety-Review-Committee-Approval-to-Proceed-to-Final-Cohorts-of-EHP-101-Phase-2a-Systemic-Sclerosis-Trial.html

Jan 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next